Search results (37)
« Back to PublicationsPAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.
Journal article
Beck DB. et al, (2026), J Clin Med, 15
Establishing a consensus definition of VEXAS flare for clinical research.
Journal article
Weeks LD. et al, (2025), Rheumatology (Oxford)
Low-risk MDS-A spotlight on precision medicine for SF3B1-mutated patients.
Journal article
Burke S. et al, (2025), Hemasphere, 9
Multi-organ abnormalities assessed by a single MRI scan in individuals with blood cancer.
Journal article
Reed S. et al, (2024), Eur J Intern Med, 128, 150 - 152
Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers
Preprint
Reed S. et al, (2023)
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Journal article
Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide.
Journal article
Chowdhury O. et al, (2021), Leukemia, 35, 1197 - 1202
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
Journal article
Chowdhury O., (2020), Leukemia
Evaluation of the detection of B-cell clonal lymphoproliferative disorders by flow cytometry or cytological analysis in lymph node aspirates obtained by endobronchial ultrasound
Conference paper
Lomas O. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 93 - 94
Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide
Conference paper
Chowdhury O. et al, (2018), BLOOD, 132
Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.
Journal article
Mead AJ. et al, (2017), J Exp Med, 214, 2005 - 2021
phagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.
Journal article
Watson AS. et al, (2015), Cell Death Discov, 1
Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo, [Cancer Cell, 25, 2014, 794-808]
Journal article
Woll PS. et al, (2015), Cancer Cell, 27, 603 - 605
pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
Journal article
Svensson T. et al, (2014), Eur J Haematol, 93, 439 - 445
pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
Journal article
Svensson T. et al, (2014), European Journal of Haematology, 93, 439 - 445
